tirzepatide surmount pubmed after intensive lifestyle intervention in adults with overweight or obesity: the SURMOUNT-3 phase 3 trial Effects of tirzepatide on circulatory – Tirzepatide SURMOUNTs obstructive sleep apnea,

combination also improved several cardiometabolic parameters, including blood pressure and glucose levels, and enhanced physical functioning

Clinical trials have demonstrated weight loss ranging from approximately 10% with GLP-1 agents at weight management doses (e.g., semaglutide 2.4 mg in the STEP trials) to over 20% with tirzepatide at higher doses (SURMOUNT trials)

with coverage, copays range from $0$250+ depending on your plan

Taking a sulforaphane supplement does not give you all of the benefits that eating something like broccoli would but it does provide you with a source of sulfur

Founders in the GLP-1 space need to understand more than market size and regulation, they must understand how capital moves in this category